Amplifai Health’s acceptance into this programme validates the company’s approach to implementing AI technology in practical healthcare settings where it can make an immediate difference in patient care.
The initiative supports the World Bank Group’s ambitious goal of delivering quality health services to 1.5 billion people by 2030.
Measles cases have increased globally, with an estimated 11 million infections in 2024—about 800,000 more than pre-pandemic levels in 2019.
The deal promises to generate up to USD90 million in savings for Gavi and participating countries over the next five years.